406 related articles for article (PubMed ID: 26621176)
41. High seroprevalence against hepatitis E virus in patients with chronic hepatitis C virus infection.
Mellgren Å; Karlsson M; Karlsson M; Lagging M; Wejstål R; Norder H
J Clin Virol; 2017 Mar; 88():39-45. PubMed ID: 28160727
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
43. [Serological antibodies comparison of a hepatitis E outbreak].
Tan CR; Bao ZY; Sun HY; Hu M; Chen Y; Chen M; Zhang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):35-8. PubMed ID: 16201469
[TBL] [Abstract][Full Text] [Related]
44. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
45. Detection of hepatitis E virus in patients sera in southern Spain.
Pérez-Gracia MT; García-Valdivia MS; Galán F; Rodríguez-Iglesias MA
Acta Virol; 2004; 48(3):197-200. PubMed ID: 15595216
[TBL] [Abstract][Full Text] [Related]
46. Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary.
Haagsman A; Reuter G; Duizer E; Nagy G; Herremans T; Koopmans M; Szücs G
J Med Virol; 2007 Jul; 79(7):927-30. PubMed ID: 17516521
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis E virus seroprevalence in Polish soldiers serving in harsh environmental conditions.
Korzeniewski K; Osińska J; Korsak J; Konior M
Int Marit Health; 2018; 69(2):137-141. PubMed ID: 29939391
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis E outbreak at a nursing home for aged people in Hokkaido, Japan, between February and March 2016.
Ishida S; Matsuura K; Yoshizumi S; Miyoshi M; Sugisawa T; Tanida M; Okano M
J Clin Virol; 2018 Apr; 101():23-28. PubMed ID: 29414183
[TBL] [Abstract][Full Text] [Related]
49. A nationwide survey of hepatitis E virus infection in the general population of Japan.
Takahashi M; Tamura K; Hoshino Y; Nagashima S; Yazaki Y; Mizuo H; Iwamoto S; Okayama M; Nakamura Y; Kajii E; Okamoto H
J Med Virol; 2010 Feb; 82(2):271-81. PubMed ID: 20029817
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis E in patients with hepatic disorders and HIV-infected patients in Croatia: is one diagnostic method enough for hepatitis E diagnosis?
Ðaković Rode O; Jemeršić L; Brnić D; Pandak N; Mikulić R; Begovac J; Vince A
Eur J Clin Microbiol Infect Dis; 2014 Dec; 33(12):2231-6. PubMed ID: 25005459
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.
Colson P; Dhiver C; Gérolami R
Clin Microbiol Infect; 2008 Dec; 14(12):1176-80. PubMed ID: 19046170
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hepatitis E virus in Egyptian children presented with minor hepatic disorders.
Aboulata AA; Ahmad MS; Shaban MM; Zayd KM; Abd El-Moktader AM
Egypt J Immunol; 2005; 12(2):71-6. PubMed ID: 17977212
[TBL] [Abstract][Full Text] [Related]
53. Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium.
Cattoir L; Van Hoecke F; Van Maerken T; Nys E; Ryckaert I; De Boulle M; Geerts A; Verhelst X; Colle I; Hutse V; Suin V; Wautier M; Van Gucht S; Van Vlierberghe H; Padalko E
J Clin Virol; 2018 Jun; 103():8-11. PubMed ID: 29602096
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain.
Fogeda M; Avellón A; Echevarría JM
J Med Virol; 2012 Jan; 84(1):71-4. PubMed ID: 22095537
[TBL] [Abstract][Full Text] [Related]
55. The Burden of Hepatitis E Infection in Chronic Liver Diseases in Croatia.
Mrzljak A; Dinjar-Kujundzic P; Jemersic L; Vilibic-Cavlek T
Vector Borne Zoonotic Dis; 2021 Jan; 21(1):67-68. PubMed ID: 32877305
[TBL] [Abstract][Full Text] [Related]
56. Investigation of Hepatitis E Seroprevalence in HIV Positive Patients by a Novel Enzyme Linked Fluorescent Assay Test.
Oz S; Altindis M; Toptan H; Koroglu M; Karabay O
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658412
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran.
Ramezani A; Velayati AA; Khorami-Sarvestani S; Eslamifar A; Mohraz M; Banifazl M; Bidari-Zerehpoosh F; Yaghmaei F; McFarland W; Foroughi M; Keyvani H; Mostafavi E; Aghakhani A
Int J STD AIDS; 2013 Oct; 24(10):769-74. PubMed ID: 23970597
[TBL] [Abstract][Full Text] [Related]
58. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection.
Gupta E; Pandey P; Pandey S; Sharma MK; Sarin SK
J Clin Virol; 2013 Oct; 58(2):374-7. PubMed ID: 23965185
[TBL] [Abstract][Full Text] [Related]
59. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR.
El-Sayed Zaki M; El-Deen Zaghloul MH; El Sayed O
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):16-20. PubMed ID: 16965347
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013.
Passos-Castilho AM; de Sena A; Reinaldo MR; Granato CF
Rev Soc Bras Med Trop; 2015; 48(4):468-70. PubMed ID: 26132499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
